Literature DB >> 22410365

IL-7 in human health and disease.

Wangko Lundström1, Natasha M Fewkes, Crystal L Mackall.   

Abstract

IL-7 plays many essential roles in human health and disease. Congenital deficiencies in IL-7 signaling result in profound immunodeficiency, polymorphisms in IL7Rα modulate susceptibility to autoimmune disease, and acquired somatic activating mutations in IL7Rα contribute to neoplastic transformation in B cell and T cell leukemia. In response to lymphopenia, IL-7 accumulates to supranormal levels, which alters T cell homeostasis by augmenting T cell reactivity toward self and cognate antigens. This physiologic response is now routinely exploited to improve the efficacy of adoptive cell therapies for cancer. Clinical trials of recombinant IL-7 have demonstrated safety and potent immunorestorative effects, and current studies are investigating whether rhIL-7 therapy can improve outcomes in chronic viral infection and in the context of cancer immunotherapies. Building upon the large fund of knowledge regarding the basic biology of IL-7, this review will discuss the many and varied roles of IL-7 in human health and disease. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22410365      PMCID: PMC3358500          DOI: 10.1016/j.smim.2012.02.005

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  91 in total

1.  Functional screening identifies CRLF2 in precursor B-cell acute lymphoblastic leukemia.

Authors:  Akinori Yoda; Yuka Yoda; Sabina Chiaretti; Michal Bar-Natan; Kartik Mani; Scott J Rodig; Nathan West; Yun Xiao; Jennifer R Brown; Constantine Mitsiades; Martin Sattler; Jeffrey L Kutok; Daniel J DeAngelo; Martha Wadleigh; Alfonso Piciocchi; Paola Dal Cin; James E Bradner; James D Griffin; Kenneth C Anderson; Richard M Stone; Jerome Ritz; Robin Foà; Jon C Aster; David A Frank; David M Weinstock
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-15       Impact factor: 11.205

2.  Down syndrome acute lymphoblastic leukemia, a highly heterogeneous disease in which aberrant expression of CRLF2 is associated with mutated JAK2: a report from the International BFM Study Group.

Authors:  Libi Hertzberg; Elena Vendramini; Ithamar Ganmore; Gianni Cazzaniga; Maike Schmitz; Jane Chalker; Ruth Shiloh; Ilaria Iacobucci; Chen Shochat; Sharon Zeligson; Gunnar Cario; Martin Stanulla; Sabine Strehl; Lisa J Russell; Christine J Harrison; Beat Bornhauser; Akinori Yoda; Gideon Rechavi; Dani Bercovich; Arndt Borkhardt; Helena Kempski; Geertruy te Kronnie; Jean-Pierre Bourquin; Eytan Domany; Shai Izraeli
Journal:  Blood       Date:  2009-11-24       Impact factor: 22.113

3.  Rearrangement of CRLF2 in B-progenitor- and Down syndrome-associated acute lymphoblastic leukemia.

Authors:  Charles G Mullighan; J Racquel Collins-Underwood; Letha A A Phillips; Michael G Loudin; Wei Liu; Jinghui Zhang; Jing Ma; Elaine Coustan-Smith; Richard C Harvey; Cheryl L Willman; Fady M Mikhail; Julia Meyer; Andrew J Carroll; Richard T Williams; Jinjun Cheng; Nyla A Heerema; Giuseppe Basso; Andrea Pession; Ching-Hon Pui; Susana C Raimondi; Stephen P Hunger; James R Downing; William L Carroll; Karen R Rabin
Journal:  Nat Genet       Date:  2009-10-18       Impact factor: 38.330

4.  Variation in IL7R predisposes to sarcoid inflammation.

Authors:  M Heron; J C Grutters; C H M van Moorsel; H J T Ruven; T W J Huizinga; A H M van der Helm-van Mil; A M E Claessen; J M M van den Bosch
Journal:  Genes Immun       Date:  2009-07-23       Impact factor: 2.676

5.  Hepatocellular carcinoma immunopathogenesis: clinical evidence for global T cell defects and an immunomodulatory role for soluble CD25 (sCD25).

Authors:  Roniel Cabrera; Miguel Ararat; Mengde Cao; Yiling Xu; Clive Wasserfall; Mark A Atkinson; Chen Liu; David R Nelson
Journal:  Dig Dis Sci       Date:  2010-02       Impact factor: 3.199

6.  IL-7 administration drives T cell-cycle entry and expansion in HIV-1 infection.

Authors:  Irini Sereti; Richard M Dunham; John Spritzler; Evgenia Aga; Michael A Proschan; Kathy Medvik; Catherine A Battaglia; Alan L Landay; Savita Pahwa; Margaret A Fischl; David M Asmuth; Allan R Tenorio; John D Altman; Lawrence Fox; Susan Moir; Angela Malaspina; Michel Morre; Renaud Buffet; Guido Silvestri; Michael M Lederman
Journal:  Blood       Date:  2009-04-20       Impact factor: 22.113

7.  Increased T-lymphocyte apoptosis in lupus correlates with disease activity and may be responsible for reduced T-cell frequency: a cross-sectional and longitudinal study.

Authors:  V Dhir; A P Singh; A Aggarwal; S Naik; Ramnath Misra
Journal:  Lupus       Date:  2009-08       Impact factor: 2.911

8.  White blood cell count abnormalities and infections in one-year follow-up of 124 patients with SLE.

Authors:  Ana Margarida Brito Dias; Maura Cristina Medeiros do Couto; Cátia Cristina Marques Duarte; Luís Pedro Bolotinha Inês; Armando Boavida Malcata
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

9.  Deregulated expression of cytokine receptor gene, CRLF2, is involved in lymphoid transformation in B-cell precursor acute lymphoblastic leukemia.

Authors:  Lisa J Russell; Melania Capasso; Inga Vater; Takashi Akasaka; Olivier A Bernard; Maria Jose Calasanz; Thiruppavaii Chandrasekaran; Elise Chapiro; Stephan Gesk; Mike Griffiths; David S Guttery; Claudia Haferlach; Lana Harder; Olaf Heidenreich; Julie Irving; Lyndal Kearney; Florence Nguyen-Khac; Lee Machado; Lynne Minto; Aneela Majid; Anthony V Moorman; Heather Morrison; Vikki Rand; Jonathan C Strefford; Claire Schwab; Holger Tönnies; Martin J S Dyer; Reiner Siebert; Christine J Harrison
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

10.  Phase I study of recombinant human interleukin-7 administration in subjects with refractory malignancy.

Authors:  Claude Sportès; Rebecca R Babb; Michael C Krumlauf; Frances T Hakim; Seth M Steinberg; Catherine K Chow; Margaret R Brown; Thomas A Fleisher; Pierre Noel; Irina Maric; Maryalice Stetler-Stevenson; Julie Engel; Renaud Buffet; Michel Morre; Robert J Amato; Andrew Pecora; Crystal L Mackall; Ronald E Gress
Journal:  Clin Cancer Res       Date:  2010-01-12       Impact factor: 12.531

View more
  58 in total

1.  Bone marrow-derived mesenchymal stromal cells promote resistance to tyrosine kinase inhibitors in chronic myeloid leukemia via the IL-7/JAK1/STAT5 pathway.

Authors:  Xiaoyan Zhang; Huaijun Tu; Yazhi Yang; Xiaoyan Jiang; Xianliang Hu; Qidong Luo; Jian Li
Journal:  J Biol Chem       Date:  2019-06-24       Impact factor: 5.157

2.  High IL-7 levels in the bone marrow microenvironment mediate imatinib resistance and predict disease progression in chronic myeloid leukemia.

Authors:  Xiaoyan Zhang; Huaijun Tu; Yazhi Yang; Qian Wan; Lijun Fang; Qiong Wu; Jian Li
Journal:  Int J Hematol       Date:  2016-06-06       Impact factor: 2.490

Review 3.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

4.  Interleukin-7 gene polymorphism rs766736182 associates with the risk of asthma in children.

Authors:  Junhua Cao; Lijun Tian; Zhenguang Li; Chonglin Zhang; Qiang Ji; Chuanling Zhang; Tong Qian
Journal:  J Clin Lab Anal       Date:  2018-09-21       Impact factor: 2.352

Review 5.  Early B lymphocyte development: Similarities and differences in human and mouse.

Authors:  Michiko Ichii; Kenji Oritani; Yuzuru Kanakura
Journal:  World J Stem Cells       Date:  2014-09-26       Impact factor: 5.326

Review 6.  It Takes Three Receptors to Raise a B Cell.

Authors:  Kaitlin C McLean; Malay Mandal
Journal:  Trends Immunol       Date:  2020-05-22       Impact factor: 16.687

7.  Association Between IL7R Promoter Polymorphisms and Multiple Sclerosis in Turkish Population.

Authors:  Hasan Simsek; Hikmet Geckin; Nilay Padir Sensoz; Edward O List; Ahmet Arman
Journal:  J Mol Neurosci       Date:  2018-11-16       Impact factor: 3.444

Review 8.  B-cell responses to HIV infection.

Authors:  Susan Moir; Anthony S Fauci
Journal:  Immunol Rev       Date:  2017-01       Impact factor: 12.988

9.  Restoring immune function of tumor-specific CD4+ T cells during recurrence of melanoma.

Authors:  Stephen R Goding; Kyle A Wilson; Ying Xie; Kristina M Harris; Aparna Baxi; Akgul Akpinarli; Amy Fulton; Koji Tamada; Scott E Strome; Paul Andrew Antony
Journal:  J Immunol       Date:  2013-03-27       Impact factor: 5.422

10.  Soluble IL7Rα potentiates IL-7 bioactivity and promotes autoimmunity.

Authors:  Wangko Lundström; Steven Highfill; Scott T R Walsh; Stephanie Beq; Elizabeth Morse; Ingrid Kockum; Lars Alfredsson; Tomas Olsson; Jan Hillert; Crystal L Mackall
Journal:  Proc Natl Acad Sci U S A       Date:  2013-04-22       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.